{"id":"W2556430588","doi":"10.1186/s13023-016-0537-5","title":"An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry","year":2016,"lang":"en","type":"review","venue":"Orphanet Journal of Rare Diseases","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Alexion Pharmaceuticals","keywords":"Medicine; Eculizumab; Alliance; General partnership; Disease; Patient advocacy; Disease registry; Quality of life (healthcare); Intensive care medicine; Family medicine; MEDLINE; Internal medicine; Nursing; Business; Political science; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000256739,0.0007354763,0.001793142,0.0001757986,0.0003336351,0.000161645,0.000716134,0.0004245749,0.0003443641],"category_scores_gemma":[0.0007056601,0.0003897513,0.0001771403,0.0006864907,0.001098719,0.0004179082,0.0001799791,0.0006009265,0.00001038046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001835264,"about_ca_system_score_gemma":0.002121129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006187091,"about_ca_topic_score_gemma":0.000004677119,"domain_scores_codex":[0.9961414,0.001408233,0.001154583,0.0005595111,0.0002581176,0.0004781493],"domain_scores_gemma":[0.9943429,0.0007238986,0.002774411,0.0006857422,0.001068249,0.0004047538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002426894,0.0006263311,0.6752208,0.006018551,0.00622683,0.0005054974,0.0002782241,2.727805e-7,4.94457e-7,0.0003285196,0.04092091,0.2674466],"study_design_scores_gemma":[0.003054908,0.0008931404,0.08877504,0.01711525,0.004735958,0.0001451743,0.0007045948,1.842979e-8,0.000001146664,0.0001422823,0.883743,0.0006894169],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02723933,0.9505225,0.000005921853,0.0001226628,0.0001818675,0.001242921,0.02060357,0.00003082034,0.00005037743],"genre_scores_gemma":[0.2284122,0.7645892,0.000015949,0.0001297541,0.0005635342,0.000146659,0.005674576,0.0001058702,0.0003622668],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8428221,"threshold_uncertainty_score":0.9998555,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02835853928980024,"score_gpt":0.3179892136303019,"score_spread":0.2896306743405016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}